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The life cycle of several viruses involves host or vir-
ally encoded small noncoding RNAs, which play im-
portant roles in posttranscriptional regulation. Small
noncoding RNAs include microRNAs (miRNAs),
which modulate the transcriptome, and small inter-
fering RNAs (siRNAs), which are involved in patho-
gen defense in plants, worms, and insects. We
show that insect and mammalian poxviruses induce
the degradation of host miRNAs. The virally encoded
poly(A) polymerase, which polyadenylates viral tran-
scripts, also mediates 30 polyadenylation of host
miRNAs, resulting in their degradation by the host
machinery. In contrast, siRNAs, which are protected
by 20O-methylation (20OMe), were not targeted by
poxviruses. These findings suggest that poxviruses
may degrade host miRNAs to promote replication
and that virus-mediated small RNA degradation
likely contributed to 20OMe evolution.
INTRODUCTION
Nucleic acid recognition is at the heart of self/non-self-discrimi-
nation. Organisms from bacteria to plants and humans sense
foreign invaders such as viruses using a variety of nucleic acid
sensors. These sensors distinguish particular nucleic acid
structures, which either leads to the direct degradation of the
molecule or the induction of signaling cascades that induce anti-
pathogen effectors. One such pathway used by plants, worms,
and insects is mediated by the small interfering RNAs (siRNAs)
derived from exogenous sources such as the invading pathogen
(viral siRNAs [vsiRNAs]), or from endogenous double-stranded
RNA derived from convergently transcribed mRNAs (endoge-
nous siRNAs [siRNAs]) (Carthew and Sontheimer, 2009). These
small RNAs are subsequently used to induce RNA interference
(RNAi) to target and degrade viral RNAs or complementary
genome-encoded transcripts (Ding, 2010). A related process,
active in the germline of insects and mammals, is the Piwi-inter-
acting RNA (piRNA) pathway; piRNAs are a distinct class of small200 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevinoncoding RNAs implicated in silencing transposable elements
in order to protect the organism from another example of self-
replicating nucleic acids (Siomi et al., 2011).
Interestingly, while chordates have maintained piRNA-medi-
ated defenses, the somatic response to virus infection is thought
to be independent of small RNA biogenesis. In place of RNAi,
chordates respond to virus infection through the recognition of
viral nucleic acids to induce type I interferons (IFN-I), cytokines
responsible for the upregulation of >250 genes, which confer an
antiviral state on the cell and its neighbors (Kawai and Akira,
2006).While theunderlying reasonas towhychordatesseemingly
replaced RNAi with IFN-I remains unknown, it is clear that small
RNAs, such asmicroRNAs (miRNAs), have thepotential to restrict
virus infection (Lecellier et al., 2005). Perhaps this is best illus-
trated by the fact that viruses can be engineered to be targeted
by miRNAs (Barnes et al., 2008; Edge et al., 2008; Kelly et al.,
2008; Perez et al., 2009; Langlois et al., 2012b; Phamet al., 2012).
miRNAs are genome-encoded small RNA species generally
derived from RNA Polymerase II transcripts and are modulated
at the levels of transcription and processing (Hagan et al.,
2009; Han et al., 2011; Heo et al., 2009; Johnson et al., 2003;
Liu et al., 2011). In brief, the primary transcript (pri-miRNA) is
recognized by a nuclear Microprocessor complex, which in-
cludes the RNase III enzyme, Drosha, and its binding partner
DGCR8 in mammals and pasha in insects (Bartel, 2004). The
nuclear Microprocessor cleaves the pri-miRNA into a precursor
miRNA (pre-miRNA) hairpin structure with a 2 nucleotide (nt) 30
overhang (Siomi and Siomi, 2010). The pre-miRNA is exported
from the nucleus and is subsequently cleaved by a cytoplasmic
RNase III enzyme, Dicer, to generate a duplex RNA of 22 nt,
flanked with 2 nt 30 overhangs (Grishok et al., 2001; Hutva´gner
et al., 2001; Ketting et al., 2001). Duplex RNA is then loaded
into an RNA-induced silencing complex (RISC), a multisubunit
structure that includes argonaute proteins (Czech and Hannon,
2011). RISC performs strand selection of the RNA duplex, based
at least in part on the thermodynamic stability of the respective 50
ends, and uses themature miRNA as a guide to induce posttran-
scriptional silencing (PTS) on target mRNAs (Bartel, 2004). In
addition to the canonical biogenesis pathway, select miRNAs
can be generated in the absence of the Microprocessor or Dicer
(Yang and Lai, 2011).
In general, miRNAs modulate transcript levels by less than
2-fold (Baek et al., 2008; Selbach et al., 2008) and have littleer Inc.
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Figure 1. Poxvirus Infection Results in Loss of Host miRNAs in Insects
(A) Schematic of miR-34 processing and corresponding miRNA duplex (middle) and mature miRNAs (bottom). The mature miRNA sequence-specific reads were
determined by deep sequencing of the 15–25 nt fraction of VACV-infected cells. Adenosines (A) in black depict nontemplated bases and percent representation
reflects the portion of the corresponding sequence in the total miRNA-specific tailed fraction.
(B) Deep-sequencing analysis of small RNA fractions of SINV-infected control (LacZ knockdown) and VACV-infected Ago1, Ago2, and control (GFP) knockdown
Drosophila cells 72 hpi (moi of 300). Numbers reflect the percentage of polyadenylated species in relation to the unmodified mature species.
(C) Northern blot of mock or VACV-infected Drosophila cells analyzed for miR-11, miR-34, miR-184, and U6 (72 hpi).
(D) Northern blot of mock or AMEV-infected Amsacta moorei cells (moi of 10) analyzed for miR-11, miR-34, miR-184, and U6 (48 hpi). See also Figure S1 and
Table S1.
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Poxviruses Mediate Host miRNA Degradationimpact on the acute cellular response to virus infection (Cullen,
2011). In contrast, there is significant interplay between miRNAs
and chronic viral infections. For example, hepatitis C virus
exploits tissue-specific miR-122 to enhance replication (Jopling
et al., 2006), while a number of nuclear DNA viruses and retrovi-
ruses have usurped this pathway by expressing virus-encoded
miRNAs to manipulate the host transcriptome (Gottwein et al.,
2011; Kincaid et al., 2012; Pfeffer et al., 2004). Taken together,
these observations suggest that viral utilization of miRNAs is
reserved for microbes with sustained replication cycles and
that virus-encoded miRNAs are restricted to pathogens with
large DNA genomes (Cullen, 2011). One interesting exception
to this generalization is the family of poxviruses, a unique group
of DNA viruses replicating exclusively in the cytoplasm.
We askedwhy poxviruses, such as vaccinia virus (VACV), have
not been reported to exploit the cellular miRNA pathway. These
large, double-stranded DNA viruses transcribe genes with long
30 UTRs (Yang et al., 2010, 2011) and could therefore benefit
from the posttranscriptional regulation provided by miRNAs.
Since cytoplasmic-mediated synthesis of miRNAs has now
been widely demonstrated (Langlois et al., 2012a; Rouha et al.,
2010; Shapiro et al., 2010, 2012) this does not explain the
apparent lack of encoded miRNAs. Thus, we investigated the
interplay between small RNAs and poxviruses. To this end, we
analyzed small RNAs from poxvirus-treated mammalian and
insect cells and discovered that infection induced tailing and
subsequent degradation of host-derived miRNAs mediated by
the virally encoded poly(A) polymerase. Interestingly, this activity
was not observed on endogenous siRNAs (esiRNAs) that contain
a terminal 20O-methyl group. Indeed, miRNAs with this modifica-
tion were also protected. Given that 20O-methylation (20OMe) of
host mRNAs and tRNAs has been implicated in discerning
between host and pathogen RNA (Daffis et al., 2010), we pro-
pose that the evolution of this RNA modification has evolved
more broadly as a tool to combat infection.Cell HosRESULTS
Poxvirus-Mediated Degradation of miRNAs in Insects
Poxviruses are an expansive class of pathogens that infect
diverse animals and encode many host evasion factors (McFad-
den, 2005; Moss, 2007). Little is known about insect-borne
poxviruses and whether they target antiviral defenses in their
insect hosts. One major antiviral defense strategy in insects is
RNA silencing, which uses small RNAs to target viral replication
(Ding, 2010). Furthermore, since insect cells utilize both miRNAs
and siRNAs, we used this model system to begin investigat-
ing the interplay between poxviruses and these diverse small
RNAs. To determine whether poxviruses interfere with RNA
silencing, we sequenced the small RNA population ofDrosophila
melanogaster cells in response to VACV infection and compared
this to infection by Sindbis virus (SINV), a virus that does not
impact small RNA silencing (Myles et al., 2008). Interestingly,
we observed an addition of nontemplated adenosines at the 30
end of miRNAs such as miR-34 (Figures 1A and 1B). In contrast,
esiRNAs were unaffected by VACV infection (Figure 1B). In
VACV-infected cells, we observed that all miRNAs (bantam,
miR-7, and miR-34 are shown) had the addition of nontemplated
adenosines at the 30 end (Figures 1A, 1B, S1A, and S1B and
Table S1). Northern blot analysis revealed that miRNAs from
VACV-infected cells migrated more slowly than in uninfected
cells, and the reduced mobility of these miRNAs was coupled
with a decrease in miRNA levels, suggesting that the modified
miRNAs were degraded (Figure 1C). This activity is reminiscent
of tailing and trimming of small RNAs in Drosophila, which has
been described previously (Ameres et al., 2010).
We next set out to determine whether miRNA polyadenylation
was dependent upon either of the two argonautes present in
these cells, Ago1 and Ago2, which mediate miRNA and siRNA
silencing, respectively (Czech et al., 2009; Kim et al., 2009; Oka-
mura et al., 2004). While the loss of Ago2 did not impact thet & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevier Inc. 201
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Figure 2. Vaccinia Virus-Mediated Degradation of miRNAs
(A) Northern blot of RNA derived from BHK cells transfected with miR-124
expressing plasmid (p124) or infected with VACV, VSV, and SV expressing
miR-124 (VV124, VSV124, and SV124, respectively) for 18 hr. Northern blots
were probed for miR-124, miR-93, and U6.
(B) Northern blot of RNA derived from BSC-1 cells infected with VV124 or
VVctrl and analyzed for miR-124, miR-93, and U6 at the indicated time points.
See also Figure S2.
Cell Host & Microbe
Poxviruses Mediate Host miRNA Degradationpolyadenylation status of miRNAs in VACV-infected cells, deple-
tion of Ago1 led to a decrease in nontemplated polyA tailing (Fig-
ure 1B and Table S1). Interestingly, extensive tailing was not
observed on miRNA star strands or endogenous siRNA (esiRNA)
esi1.1 and esi2.1 (Figures 1B and S1C and Tables S1A and S1B),
although the basal levels of tailing likely reflect a small degree of
cross-loading of eachof these small RNAs intoAgo1 versusAgo2
(Czech et al., 2009; Fo¨rstemann et al., 2007; Ghildiyal et al., 2010;
Okamura et al., 2009; Tomari et al., 2007). Further, upon loss of
Ago2we observed an increase in the tailing of esiRNAs, again re-
flecting the cross-loading of these small RNAs into an Ago1-con-
taining complex in the absence of Ago2 (Figure 1B). Together,
these data suggest that Ago1-loaded small RNAs are tailed
and degraded during poxvirus infection.
Given the artificial nature of mammalian poxvirus infection of
insect cells, we tested a bona fide insect- poxvirus pair. We chal-
lenged the tiger mothAmsactamoorei cells withAmsactamoorei
entomopoxvirus (AMEV) and found that infection also resulted in
the specific loss of all mature miRNAs tested, including miR-11,
miR-34, and miR-184 (Figure 1D). Other small RNAs such as U6
were unaffected by AMEV infection (Figure 1D).
VACV-Mediated Degradation of miRNAs in Mammalian
Cells
We next set out to determine whether VACV, which normally
infects mammals, also targets mammalian miRNAs for degrada-
tion. As previous studies have established that cytoplasmic RNA
viruses can be engineered to encode and generate functional
miRNAs (Langlois et al., 2012a; Rouha et al., 2010; Shapiro
et al., 2010, 2012), we engineered VACV to synthesize the
neuronal-specific miR-124 (VV124) as a tool to study virus-medi-
ated tailing. To obtain expression throughout the viral replication
cycle, we placed the miRNA under transcriptional control of a
VACV synthetic early-late promoter that is transcribed by the
virus-encoded DNA-dependent RNA polymerase (Moss, 2007).
This allowed us to directly compare plasmid-derived miR-124
(p124) transfections and cells infected with either SINV or Vesic-
ular Stomatitis Virus (VSV) expressing miR-124 (SV124 and
VSV124, respectively) (Figure 2A). Interestingly, while SV124,
VSV124, and p124 demonstrated robust miRNA accumulation,
VV124 infections resulted in low levels of miR-124 synthesis
and a nearly complete loss of endogenous miR-93, while U6
RNA levels were unaffected. Furthermore, we observed that
while the pri- and pre-miR-124 derived from VV124 ran as a
single species, mature miR-124 products ranged from 22–35
nt, suggesting improper processing or a posttranscriptional
modification similar to our observations in insect cells.
To explore this phenomenon further, VV124 infection kinetics
were performed (Figure 2B). These data demonstrated produc-
tion of a single miR-124 species of 22 nt as early as 3 hr post-
infection (hpi). Levels of miR-124 increased at 6 hpi, and we also
observed the generation of the slower migrating products
ranging from 20–35 nt, reminiscent of the miRNA tailing that
results following perfect mRNA binding (Ameres et al., 2010).
Beyond 6 hpi, total levels of the mature miR-124 stabilized, but
the majority of VV124-derived small RNAs were greater than
22 nt, with a dominant species migrating at 30 nt in length.
The appearance of the 30 nt product correlated with the loss
of endogenous miR-93, where we also observed a slower202 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevimigrating product. This activity was not cell type- or species-
specific, as it was equally apparent in other cell types (Figures
2A, 2B, S2A, and S2B). Furthermore, degradation of endoge-
nous miR-93 was not specific to VV124 infection, as wild-type
VACV, lacking the miR-124 locus (VVctrl), also resulted in loss
of this endogenous miRNA (Figures 2B and S2).
Next, we determined the mechanism by which VACV-medi-
ated miR-124 synthesis occurred. Processing could be medi-
ated in a canonical manner, as observed for engineered influenza
A virus expressing miR-124 (IAV124), although influenza repli-
cates in the nucleus and VACV replicates exclusively in the cyto-
plasm. Alternatively, noncanonical processing was observed for
cytoplasmic RNA viruses such as SV124 and VSV124 (Langlois
et al., 2012a; Rouha et al., 2010; Shapiro et al., 2010, 2012).
VV124 infection of wild-type murine fibroblasts resulted in the
production of miR-124 species ranging from 22 nt to greater
than 30 nt in length with a corresponding decrease in endoge-
nousmiR-93 expression (Figure S2B). DGCR8, which is essential
for canonical processing of pri- to pre-miRNA (Wang et al.,
2007), was dispensable. Interestingly, despite normal pre-miR-
124 levels, VACV-derived mature miR-124 was completely ab-
sent in these conditions, suggesting that the lack of endogenous
miRNAs may accelerate miR-124 degradation. This was sup-
ported by kinetic experiments in cells treated with Cre to disrupt
DGCR8 expression, in which low levels of VACV-mediated miR-
124 is detectable, even in the absence of endogenous miR-
93 (Figure S2C). Furthermore, as expected, no VACV-mediated
miRNA production was evident in the absence of Dicer, which
is required both for canonical and noncanonical processing (Fig-
ure S2A). Taken together, these data demonstrate that VV124-
mediatedmiRNA generation requires a noncanonical processing
pathway similar to that described for other cytoplasmic viruses
(Langlois et al., 2012a; Rouha et al., 2010; Shapiro et al., 2010,
2012).er Inc.
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Figure 3. An Early Viral Factor Mediates VACV-Induced miRNA
Modification
Northern blot of RNA derived from BHK cells mock treated or infected with
VV124 at anmoi of 10 in presence or absence of cytosine arabinoside (AraC) or
cyclohexamide (CHX) and harvested at the indicated hours postinfection (hpi).
Northern blots were probed for miR-124, miR-93, and U6. See also Figure S3.
Cell Host & Microbe
Poxviruses Mediate Host miRNA DegradationAn Early Viral Factor Mediates VACV-Induced miRNA
Modifications
Expression of the200 VACV-encoded proteins occurs sequen-
tially through the regulation by stage-specific promoters and
transcription factors; immediately after infection, early genes
are expressed, followed by viral genome replication and subse-
quently intermediate followed by late gene expression (Moss,
2007). VACV infection of Drosophila cells results in early gene
expression, but arrests prior to intermediate gene expression
(Bengali et al., 2011; Moser et al., 2010), suggesting a require-
ment for an early gene product. To verify this hypothesis, we
used cytosine arabinoside (AraC) and cycloheximide (CHX) to
block late and early-late protein synthesis, respectively. Treat-
ment of VV124-infected cells with CHX allowed for robust ex-
pression of the miRNA and blocked laddering of miR-124 and
the degradation of endogenous miR-93 (Figure 3). In contrast,
loss of endogenous miR-93 was observed upon treatment with
AraC, which only allows for early gene expression. Western
blot analysis of lysates obtained from these samples validated
the block of early/late (E3/A27) and late (A27) protein synthesis
caused by CHX and AraC, respectively (Figure S3). Taken to-
gether, these data suggest that the posttranscriptional modifi-
cation or improper processing of host miRNAs is dependent
on an early viral gene product or an encapsidated virion protein
released upon uncoating in both insect and mammalian cells
(Joklik and Becker, 1964).
VACV Infection Induces miRNA-Specific
Polyadenylation
In an effort to determine the nature of the slowermigrating VACV-
derived miR-124 products, we deep sequenced the 20–35 ntCell HosRNAs from VV124-infected cells and analyzed the small RNA
populations by deep sequencing. This analysis demonstrated
that greater than 50% of VACV-derived miR-124 contained 7–9
adenosines on the 30 end (Figure 4A and Table S2). Interestingly,
this same level of polyadenylation was not observed on miR-124
star. As this pattern of polyadenylation could, in part, be ex-
plained by tailing of the pre-miRNAs prior to Dicer cleavage,
we subsequently analyzed miRNAs produced from the 50 end
of the hairpin, such as miR-31. Analysis of small RNAs ranging
from 20 to 35 nt revealed that, similar to miR-124, miR-31, as
well as all other host miRNAs, were polyadenylated with greater
than 50% of the captured reads containing 7–9 adenosines (Fig-
ure 4B and Table S2). Furthermore, we found little evidence for
the polyadenylation of miRNA star strands, nor non-miRNAs
captured in this RNA fraction (Table S2). The polyadenylation
of miR-124 and miR-31 was also evident by northern blot,
demonstrating tailing in the presence of VV124 infection (Fig-
ure 4C), whereas pre-miR-124, miR-124*, tRNA, and U6 all ap-
peared unmodified (Figure 4D).
VACV-Induced miRNA Polyadenylation Results in
Degradation
To determine whether the degradation of endogenous miRNAs
was biased in any way, we performed a second round of small
RNA deep sequencing on the 19–22 nt fraction of VV124-
infected murine embryonic fibroblasts (Tables S3A and S3B).
This analysis demonstrated that infection led to a 30-fold reduc-
tion of all endogenous miRNAs, with the exception of VACV-
produced miR-124, while still maintaining the same overall small
RNA profile, similar to our results in Drosophila cells (Figure 5A
and Table S1A). Again, we did not observe any modification of
non-miRNAs in this fraction (Table S3B).
Nontemplated tailing is emerging as a general mechanism
used to degrade miRNAs (Ameres et al., 2010; Kim et al., 2009;
Li et al., 2005; Marcinowski et al., 2012; Shen and Goodman,
2004; van Wolfswinkel et al., 2009). In order to investigate
whether the polyadenylation of miRNAs was directly responsible
for degradation and to discern whether a cellular- or a virus-en-
coded nuclease was involved, we designed miR-124 mimetics
containing no (124), one (124 + 1A), or seven (124 + 7A) nontem-
plated adenosines at the 30 end (Figure S4) and transfected these
into mammalian cells. Small RNA northern blot analyses of these
miR-124 mimetics demonstrated that the degradation of tailed
miRNAs was directly related to polyadenylation and was not
the result of a virus-encoded nuclease, as the synthetic tailed
miR-124 containing seven adenosines was degraded in the ab-
sence of infection (Figure 5B). Altogether, these data suggest
that poxvirus-induced polyadenylation is specific for miRNAs,
does not display a sequence-specific bias, and results in degra-
dation by the cell.
VACV VP55 Is Both Necessary and Sufficient for miRNA
Polyadenylation
VACV polyadenylates its own transcripts to generate mature
viral mRNAs, and the virus-encoded heterodimeric poly(A) poly-
merase is responsible for this activity. The larger subunit, VP55,
initiates polyadenylation and possesses all of the catalytic func-
tions, whereas the processivity factor, VP39, extends the poly(A)
tail (Gershon et al., 1991; Moss et al., 1975). As the modificationt & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevier Inc. 203
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Figure 4. VACV Infection Induces miRNA-Specific Polyadenylation
(A and B) Schematic of pre-miR-124 (A) and pre-miR-31 (B) processing intomiRNA duplex (middle) andmature miRNA (bottom). miRNA sequence-specific reads
were determined by deep sequencing of the 20–35 nt fraction of VV124-infected BHK cells. Adenosines (A) in black depict nontemplated bases, and percent
representation reflects the portion of the corresponding sequence represented in the total miRNA-specific tailed fraction.
(C) Northern blot analysis of RNA derived from BHK cells mock treated or infected with VV124 for 18 hr (moi of 10). Small northern blots were probed for miR-124,
miR-31, and U6.
(D) Same as in (C) but probed for miR-124*, tRNA, and U6. See also Table S2.
Cell Host & Microbe
Poxviruses Mediate Host miRNA Degradationof miRNAs was limited to the addition of less than ten adeno-
sines, we speculated that VP55, which is also an early VACV
gene product and is encapsulated in the virion (Assarsson
et al., 2008; Chung et al., 2006; Moss et al., 1975), was the prob-
able virus component responsible. To test this, we transfected
either control (scrambled [scbl]) or VP55-specific siRNAs and
infected with VV124. Control siRNAs had no effect on the polya-
denylation of VACV-derived miR-124 or the degradation of en-
dogenous miR-93 (Figure 6A). In contrast, cells treated with
siRNAs against VP55 produced VACV-derived miR-124 with no
evidence of modification and did not lead to the degradation of
endogenous miR-93 (Figure 6A). While these data suggest that
VP55 is necessary for the polyadenylation and degradation of
miRNAs in VACV-infected cells, loss of VP55 also resulted in
an expected block in VACV replication (compare early protein
expression E3 to the late A27 virus product) (Figure S5A).
Thus, we next determined whether VP55 was sufficient to
confer this activity. Flag-tagged VP39 and/or VP55 were trans-
fected into fibroblasts in the presence or absence of plasmid-
derived miR-124 (Figure S5B). At 36 hr posttransfection (hpt),
northern blot analysis revealed that expression of VP55 alone
was sufficient to induce specific tailing of miR-124 (Figure 6B).
Furthermore, endogenous miR-93 was lost upon expression of204 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 ElseviVP55 (Figure 6C). In contrast, VP39 had no impact on either
miRNA (Figures 6B and 6C). Again, VP55 expression did not
impact miR-124*, tRNA, or U6, demonstrating a similar speci-
ficity profile as observed during VACV infection. Taken together,
these results demonstrate that VACV VP55 is both necessary
and sufficient for the specific polyadenylation of miRNAs.
To determine whether polyadenylation had an impact on
miRNA-mediated silencing, we cotransfected fibroblasts with
epitope-tagged VP55 together with a miR-124-expressing plas-
mid (p124) and a miR-124-targeted GFP (GFP-124T) reporter
construct containing four perfect miR-124 target sites (Fig-
ure 6D). As expected, plasmid-derived miR-124 expression
was robust and was extensively modified in the presence of
VP55. Moreover, expression of miR-124 resulted in a complete
loss of GFP, whereas coexpression of VP55 rescued GFP ex-
pression, suggesting that miRNA tailing rendered miR-124 non-
functional (Figure 6D).
As VP55 represents a critical component of the poxviral repli-
cation machinery, determining the physiological requirement for
this protein in the context of miRNA degradation is difficult, as
these activities cannot be separated. As such, in an effort to
determine whether host miRNAs interfere with poxvirus repli-
cation, we reconstituted miRNAs in VACV-infected cells wither Inc.
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Figure 5. VACV-Mediated miRNA Degradation Is Unbiased
(A) Deep-sequencing analysis (19–22 nt fraction) of mock and VV124-infected
murine embryonic fibroblasts, 24 hpi (moi of 10). VACV-derived miR-124 (VV-
miR-124) is depicted.
(B) Northern blot ofmammalian cells transfectedwith synthetic wild-type (miR-
124) or tailed (miR-124(+1A)/miR-124(+7A)) miRNAs for 16 hr and probed for
miR-124, miR-124*, miR-93, and U6. See also Figure S4 and Table S3.
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Poxviruses Mediate Host miRNA DegradationmiRNA duplex mimetics or control mimetics and determined
the impact on virus replication. To this end, we transfected
a pool of the let-7 family, miR-21, miR-22, andmiR-93.We chose
this group because they represent greater than 50%of total miR-
NAs found in fibroblasts (Table S3B). While VACV infection
reduced endogenous miRNAs to undetectable levels, the trans-
fected mimetics were not degraded, even at 60 hpi (Figures
S5C). In comparing virus replication in miRNA-reconstituted
and control cells, we monitored the two distinct infectious forms
of VACV: the more abundant intracellular mature virus (IMV) that
remains in the infected cell until lysis, and an extracellular envel-
oped virus (EEV) that is propelled along actin tails to infect more
distant cells or is released (Moss, 2007). At 60 hpi, total virus
levels (IMV and EEV) were significantly reduced (p = 0.0038),
demonstrating approximately half the presence of total virus inCell Hoscells reconstituted with miRNA mimetics (Figure S5D). Impor-
tantly, we observed the same reduction in EEV titer in
the supernatants of miRNA mimetic-transfected cells compared
to control transfections (Figure S5E). Given that EEVs play a
fundamental role in virus dissemination, a 50% loss of EEVs
would likely result in a significant in vivo attenuation of the virus
(Payne, 1980; Payne and Kristensson, 1985). We conclude from
these data that host miRNAs, including the let-7 family, miR-
21, miR-22, and miR-93, reduce the production of infectious
virions, either directly or indirectly, and that VACV counteracts
this activity.
30-Terminal Nucleotide Methylation Protects Small
RNAs from VACV-Mediated Ago-Dependent
Polyadenylation
With no evidence of miRNA star modifications, we hypothesized
that polyadenylation occurred after strand selection in RISC. To
determine whether VACV-modified miRNAs were loaded into
RISC, we immunoprecipitated Ago2-associated RNA fractions
from VV124-infected cells (Figure 7A). Input RNA from epitope-
tagged Ago2- or GFP-expressing cells demonstrated the char-
acteristic polyadenylation of VACV-derived miR-124 and loss
of endogenous miR-93. Furthermore, RNA from corresponding
immunoprecipitations demonstrated that, while no miRNAs as-
sociated with GFP, nonadenylated miR-124*, miR-93, and all
species of miR-124 were associated with Ago2. These data
implicate that miRNA tailing occurs sometime after strand selec-
tion by VP55 interacting with Ago or another component of
mature RISC.
To further explore the mechanism underlying the specificity
of VP55-mediated miRNA polyadenylation, we examined the
differences between miRNAs and other cellular small RNAs.
Our deep-sequencing results from Drosophila cell infections
demonstrated that, while miRNAs were degraded, esiRNAs
were spared (Figures 1B and S1C). Drosophila siRNAs are
selectively 20O-methylated (20OMe) on the 30-terminal nucleo-
tide (Horwich et al., 2007; Kawamura et al., 2008; Saito et al.,
2007), and studies have shown that 20OMe protects small
RNAs from degradative pathways including 30-end uridylation-
dependent decay and 30-to-50 exonuclease-mediated degrada-
tion (Ameres et al., 2010; Li et al., 2005; Yu et al., 2005).
We therefore reasoned that the VACV-mediated polyadenyla-
tion-dependent decay pathway may also be blocked by this
modification. Indeed, VACV infection of cells transfected with
miR-124/miR-124* duplexes with 20OMe modifications on
miR-124 were completely protected from VACV-mediated poly-
adenylation, while the unmethylated form was targeted (Figures
7B and 7C). miR-124*, despite the lack of a 30 20OMe conju-
gation, also showed no evidence of tailing, suggesting that
protection of the passenger strand may be due to the fact
that polyadenylation occurs after strand selection, in agreement
with results observed from de novo infections where star
strands are not modified (Figures 1B, 4D, and 7A). These find-
ings suggest that poxviruses inactivate Ago-loaded regulatory
small RNAs unless they are protected by terminal 20OMe.
VP55-mediated destruction of miRNAs offers an explanation
why poxviruses, with their large DNA genomes, seemingly do
not encode and utilize miRNAs in similar ways as many herpes-
viruses do (Cullen, 2011).t & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevier Inc. 205
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Figure 6. VACV VP55-Mediated Tailing
Inhibits miRNA Function
(A) Analysis of BHK cells transfected with scram-
bled (scbl) or VP55-specific siRNAs. Six hours
posttransfection, cells were mock treated or in-
fected with VV124 for 16 hr (moi of 10). Small
northern blots were probed for miR-124, miR-93,
and U6.
(B) Analysis of BHK cells mock treated or trans-
fected with plasmids expressing miR-124 (p124)
and Flag-tagged VP55 and/or VP39 for 36 hr.
Northern blots were probed for miR-124, miR-
124*, and U6.
(C) Analysis of BHK cells mock treated, infected
with VVctrl, or transfected with plasmids ex-
pressing Flag-tagged VP55 and/or VP39 for 36 hr.
Northern blots were probed for miR-93, tRNA,
and U6.
(D) BHK cells transfected with plasmids express-
ing miR-124 (p124), GFP-containing four tandem
miR-124 target sites in the 30 UTR (GFP-124T), and
control or Flag-tagged VP55 for 36 hr. Top three
panels: northern blot probed for miR-124, miR-93,
and U6. Bottom three panels: immunoblots pro-
bed for Flag, GFP, and actin. See also Figure S5.
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Following the discovery that cytoplasmic viruses were capable
of generating functional miRNAs, we set out to explore the inter-
play between poxviruses and miRNAs. This led to the discovery
that poxviruses tailed miRNAs and induced their degradation. As
miRNA tailing was due to 30 polyadenylation, this implicated the
catalytic subunit of the viral poly(A) polymerase, VP55. Impor-
tantly, VP55 is both an early gene product and is encapsulated
in the virion and is both necessary and sufficient for miRNA
tailing. VP55 induced the specific polymerization of 2–7 adeno-
sines onto miRNAs after strand selection, as neither the star
strand nor comparably sized cellular RNAs were tailed. Further-
more, we found that endogenous siRNAs were protected from
polyadenylation. In contrast to miRNAs, siRNAs are known to
be methylated, which led to the discovery that 20OMe protects
these small antiviral siRNAs of the cell.
VP55-mediated destruction of miRNAs could have arisen for
two distinct reasons. First, it may have evolved to evade
miRNA-mediated restriction either as a result of its long 30 UTRs
or more indirectly through the control of endogenous cellular206 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevier Inc.factors. Consistent with this is our obser-
vation that restoring miRNA function
during VACV infection reduces viral repli-
cation (Figures S5D and S5E). Alterna-
tively, it may have evolved to evade more
generalized antiviral small RNA restriction
present in lower organisms such as
insects, as observed for AMEV infection
of Amsacta moorei cells (Figure 1D). This
evolutionary maintenance would then
suggest that 20OMe evolved as a cellular
response to protect antipathogen small
RNAs during poxvirus infection. Certainlythe fact that poxviruses, as a family, can infect both invertebrate
and vertebrate hosts suggests that a common ancestor may
have evolved this antagonistic activity as a means of innate
immune evasion. In either case, the activity of VP55 would have
provided the virus an environment that lacked a large pool of
non-20OMe small noncoding RNAs, which may have resulted in
a dependency on this activity, regardless of its original necessity.
Interestingly, the utilization of a small RNA methyltransferase
appears relatively recently in our evolutionary history. The rela-
tionships between different eukaryotic lineages of HEN1, the
methyl transferase of siRNAs and piRNAs in Drosophila, suggest
that it originates in a common ancestor of Eukaryota, before the
divergence of the Plantae and Metazoa/Fungi (Tkaczuk et al.,
2006). This is supported by the fact that HEN1 orthologs have
not be detected in Archaea or in primitive Eukaryota and is in
stark contrast to the Ago protein family, which is more deeply
conserved (Murphy et al., 2008). Equally interesting is the fact
that HEN1 appears to have been horizontally transferred to bac-
teria (Tkaczuk et al., 2006), suggesting a common evolutionary
pressure resulted in convergent utilization of 20OMe for defense.
Indeed, recent studies have suggested that Escherichia coli
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Figure 7. 30-Terminal Nucleotide Methyla-
tion Protects Small RNAs from VACV-Medi-
ated Ago-Dependent Polyadenylation
(A) Northern blot analysis of RNA derived from
BHK cells transfected with plasmids expressing
miR-124 (p124) and Flag-tagged Ago2 or GFP.
Twenty-four hours posttransfection, cells were
mock infected or infected with VV124 (moi of 10).
Cell lysates were subjected to coimmunoprecipi-
tations at the indicated hours postinfection (hpi)
using anti-Flag antibody. Blots were probed for
miR-124, miR-124*, and miR-93.
(B) Schematic of synthetic miR-124 duplexed
miRNAs including unmethylated passenger strand
(top) and20OMemiRNA-124guide strand (bottom).
(C) Northern blot of RNA derived from BHK cells
transfected with the miRNAs depicted in (B).
Transfected cells were mock treated or VVctrl
infected for 16 hr. Northern blot were probed for
miR-124, miR-124*, miR-93, and U6.
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Poxviruses Mediate Host miRNA Degradationutilize 20OMe to mask their tRNA from being recognized as
foreign by TLR-7 (Gehrig et al. 2012; Jo¨ckel et al., 2012). Further-
more, plants also use 20OMe as a means of microbial protection.
Loss of HEN1 renders Arabidopsis hypersusceptible to
Cucumber Mosaic Virus (Boutet et al., 2003). In addition, Carna-
tion Italian ringspot virus (CIRV), Tobacco etch virus (TEV), and
Zucchini yellow mosaic virus (ZYMV) have all been found to
inhibit HEN1 activity (Jamous et al., 2011; Lo´zsa et al., 2008).
Thus, 20OMe may be a prevalent mechanism used to protect
small RNAs and allow them to target pathogens for defense.
Indeed, the interplay between 20OMe and the antiviral response
is not limited to small RNA-mediated silencing. Recently, the 50
cap of mRNA was also demonstrated to contain a 20OMe modi-
fication as a means of distinguishing cellular from viral RNA (Daf-
fis et al., 2010; Zu¨st et al., 2011). In turn, viruses have evolved
mechanisms to 20O-methylate their own messages. Indeed,
VP39, the other component of the viral poly(A) polymerase,
also has methyltransferase activity and modifies VACV mRNAs
to escape detection of this cap-sensing pathway (Lockless
et al., 1998). Thus the complex VP55/VP39 provides both func-
tions required for replication (capping and polyadenylation) as
well as evasion tactics (degradation of small RNAs and methyla-
tion of mRNAs). Given the interplay between microbes and
20OMemodification, it is tempting to speculate that RNAmethyl-
ation emerged in a response to evolutionary pressure, as part ofCell Host & Microbe 12, 200–210the timeless struggle between host and
pathogen. Clearly, identification of these
interactions and the scope of 20OMe utili-
zation in the antiviral response warrant
further investigation.
EXPERIMENTAL PROCEDURES
Virus Design and Infections
Recombinant VACV expressing miR-124 (VV124)
was generated as described previously (Blasco
and Moss, 1995). A mutant non-plaque-forming
VACV (strain Western Reserve) deficient of the
F13L gene (vRB12), and the VACV transfer plasmidpRB21 containing a functional F13L gene, a VACV synthetic early/late
promoter, and flanking sequences of VACV DNA for homologous recombina-
tion have been described previously (Blasco and Moss, 1995). F13L encodes
a component of the viral outer envelope required for efficient viral spread.
The miR-124-2 murine locus (chr3:17,695,454–17,696,037) was cloned into
pRB21 and transfected into vRB12-infected cells. Recombinant viruses were
identified and isolated by their ability to form plaques. VVctrl contains the
miR-124-2 locus in inverse orientation under control of the synthetic early-
late promoter. Viruses were propagated, purified, and titrated using standard
methodology.Cells, Infections, and Transfections
BSC-1, BHK21, and murine fibroblasts were grown at 37C in DMEM media
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-strepto-
mycin (P/S). Drosophila DL1 cells were grown and maintained at 25C
in complete Drosophila media (Schneider’s Drosophila medium [GIBCO])
containing 10% FBS, GlutaMAX (GIBCO), and 1% P/S (GIBCO). Amsacta
moorei Ld652 cells were obtained from Rollie Clem (Kansas State Univer-
sity, Manhattan, KS) and grown and maintained at 27C in Grace’s insect
media supplemented with 10% FBS and 1% P/S (GIBCO). VACV infections
of mammalian and Drosophila cells were performed at an moi of 10 at
37C and at an moi of 300 at 25C, respectively (Bengali et al., 2011; Moser
et al., 2010). Cytosine b-D-arabinofuranoside (AraC; Sigma-Aldrich) and
cycloheximide (CHX; Sigma-Aldrich) were used (40 mg/ml and 100 mg/ml,
respectively). Infections with Sindbis virus expressing miR-124 (SV124) (Sha-
piro et al., 2010) and vesicular stomatitis virus expressing miR-124 (VSV124)
(Langlois et al., 2012a) were performed at an moi of 1. AMEV was obtained
from S.A. Perera (Great Lakes Forestry Centre, Ontario, Canada). AMEV, August 16, 2012 ª2012 Elsevier Inc. 207
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Poxviruses Mediate Host miRNA Degradationinfections of Ld652 were performed at an moi of 10 at 27C for 48 hr (Becker
et al., 2004).
Transfections and RNA Interference
Plasmids were transfected into cells in suspension using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. Unmodified, 30-20O-
methylated, or polyadenylated miR-124 and miR-124* (Integrated DNA Tech-
nologies) or siRNAs (Thermo Scientific) were transfected into BHK cells in
suspension using RNAiMAX (Invitrogen). Cells were infected with VACV 6 hr
posttransfection and harvested 16 hr posttransfection. dsRNA for RNAi in
Drosophila were designed using the SnapDragon design tool (http://www.
flyrnai.org/), and PCR amplification was performed using Drosophila genomic
DNA as a template. PCR products were then used as templates for in vitro
transcription using the MEGAScript T7 kit (Ambion) as per manufacturer’s
instructions. dsRNA was purified using an RNeasy Kit (QIAGEN) follow-
ing the manufacturer’s protocol. For knockdown experiments, cells were
passaged into serum-free media and plated into wells containing dsRNA at
4 mg/2.5 3 106 cells in six-well plates. One hour later, complete media was
added. Three days later, the cells were infected with VACV at the indicated
moi in 2% FBS.
Small RNA Northern Blot
Northern blots were reproduced a minimum of three independent times.
Depicted blots reflect a representation of triplicate results. Small RNA northern
blots were performed as described previously (Pall and Hamilton, 2008).
Probes used can be found in Supplemental Experimental Procedures.
Western Blot
Western blots were generated from total protein separated on a 15% SDS-
PAGE gel. Resolved protein was transferred to nitrocellulose (Bio-Rad),
blocked for 1 hr with 5% skim milk at 25C, and then incubated with the indi-
cated antibody overnight at 4C. The VACV E3L (BEI Resources, NR-4547)
and A27L antibodies (BEI Resources, NR-567) were used at a concentra-
tion of 1 mg/ml. VACV E1L antibody (kind gift from R. Condit, University of
Florida, Gainesville) was used (1:5,000). Anti-Flag (Sigma), anti-GFP (Santa
Cruz Biotechnology), and anti-pan-actin (NeoMarkers) antibodies were used
(0.04 mg/ml). Secondary mouse and rabbit antibodies (GE Healthcare) were
used at a 1:5,000 dilution for 1 hr at 25C. All antibodies were diluted in 5%
skim milk. Immobilon Western Chemoluminescent HRP substrate (Millipore)
was used as directed.
Immunoprecipitations
BHK cells were transfected with either Flag-tagged Ago or Flag-tagged GFP
(Addgene Cat Numbers 19888 and 22612, respectively) and, where indicated,
cotransfected with a plasmid expressing pri-miR-124. Twenty-four hours
posttransfection, cells were infected with VV124 (moi of 10), and protein
extracts were harvested at the indicated time points. Immunoprecipitations
were performed overnight at 4C using 10 mg anti-Flag antibody (Sigma) and
protein G PLUS Agarose (Santa Cruz Biotechnology). Beads were washed
and RNA was extracted with TRIzol (Ambion) and analyzed by small RNA
northern blot.
Deep Sequencing
Deep sequencing in mammalian cells was performed on BHK21 (20–35 nt
fraction) and on wild-type murine fibroblasts (19–22 nt fraction) infected with
VV124 at an moi of 10 for 24 hr. Isolation, purification, and amplification of
small RNA species were performed as previously described (Langlois et al.,
2012a). Small RNA libraries were generated as previously described (Pfeffer
et al., 2004). Briefly, total RNA from indicated samples was isolated using
TRIzol (Invitrogen) and spiked with radiolabeled size markers prior to size frac-
tionation on a 12% denaturing Tris-urea gel (SequaGel, National Diagnostics).
Deep sequencing ofDrosophila cells was performed with 40 mg total RNA from
virus-infected DL1 cells. RNA was separated by electrophoresis on a 15%
TBE-urea gel, and RNA molecules 15–25 nt were excised and eluted from
the gel fragments. Following ethanol precipitation, smRNA-seq libraries
were produced using the Small RNA Sample Prep v1.5 kit (Illumina, San Diego,
CA) as per manufacturer’s instructions.208 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 ElseviSUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2012.05.019.
ACKNOWLEDGMENTS
S.C. and B.R.t. acknowledge the gracious support of the BurroughsWellcome
Fund. This work was supported by grants from the National Institutes of Health
(R01AI074951,U54AI057168) to S.C. and the Army Research Office (59471LS)
to B.R.t. Additionally, we would like to thank Drs. G. Hannon (HHMI, Cold
Spring Harbor Laboratories) for performing a subset of the deep sequencing,
R. Condit (University of Florida, Gainesville) for the VACV E1L antibody, S.A.
Perera (Great Lakes Forestry Centre, Ontario, Canada) for Amsacta moorei en-
tomopoxvirus (AMEV), and R. Clem (Kansas State University, Manhattan, KS)
for Amsacta moorei Ld652 cells.
Received: December 13, 2011
Revised: April 18, 2012
Accepted: May 31, 2012
Published: August 15, 2012
REFERENCES
Ameres, S.L., Horwich, M.D., Hung, J.H., Xu, J., Ghildiyal, M., Weng, Z., and
Zamore, P.D. (2010). Target RNA-directed trimming and tailing of small
silencing RNAs. Science 328, 1534–1539.
Assarsson, E., Greenbaum, J.A., Sundstro¨m, M., Schaffer, L., Hammond, J.A.,
Pasquetto, V., Oseroff, C., Hendrickson, R.C., Lefkowitz, E.J., Tscharke, D.C.,
et al. (2008). Kinetic analysis of a complete poxvirus transcriptome reveals an
immediate-early class of genes. Proc. Natl. Acad. Sci. USA 105, 2140–2145.
Baek, D., Ville´n, J., Shin, C., Camargo, F.D., Gygi, S.P., and Bartel, D.P. (2008).
The impact of microRNAs on protein output. Nature 455, 64–71.
Barnes, D., Kunitomi, M., Vignuzzi, M., Saksela, K., and Andino, R. (2008).
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy
for developing attenuated virus vaccines. Cell Host Microbe 4, 239–248.
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and func-
tion. Cell 116, 281–297.
Becker, M.N., Greenleaf, W.B., Ostrov, D.A., andMoyer, R.W. (2004). Amsacta
moorei entomopoxvirus expresses an active superoxide dismutase. J. Virol.
78, 10265–10275.
Bengali, Z., Satheshkumar, P.S., Yang, Z., Weisberg, A.S., Paran, N., and
Moss, B. (2011). Drosophila S2 cells are non-permissive for vaccinia virus
DNA replication following entry via low pH-dependent endocytosis and early
transcription. PLoS ONE 6, e17248.
Blasco, R., and Moss, B. (1995). Selection of recombinant vaccinia viruses on
the basis of plaque formation. Gene 158, 157–162.
Boutet, S., Vazquez, F., Liu, J., Be´clin, C., Fagard, M., Gratias, A., Morel, J.B.,
Cre´te´, P., Chen, X., and Vaucheret, H. (2003). Arabidopsis HEN1: a genetic link
between endogenous miRNA controlling development and siRNA controlling
transgene silencing and virus resistance. Curr. Biol. 13, 843–848.
Carthew, R.W., and Sontheimer, E.J. (2009). Origins and Mechanisms of
miRNAs and siRNAs. Cell 136, 642–655.
Chung, C.S., Chen, C.H., Ho, M.Y., Huang, C.Y., Liao, C.L., and Chang, W.
(2006). Vaccinia virus proteome: identification of proteins in vaccinia virus
intracellular mature virion particles. J. Virol. 80, 2127–2140.
Cullen, B.R. (2011). Viruses and microRNAs: RISCy interactions with serious
consequences. Genes Dev. 25, 1881–1894.
Czech, B., and Hannon, G.J. (2011). Small RNA sorting: matchmaking for
Argonautes. Nat. Rev. Genet. 12, 19–31.
Czech, B., Zhou, R., Erlich, Y., Brennecke, J., Binari, R., Villalta, C., Gordon, A.,
Perrimon, N., and Hannon, G.J. (2009). Hierarchical rules for Argonaute
loading in Drosophila. Mol. Cell 36, 445–456.er Inc.
Cell Host & Microbe
Poxviruses Mediate Host miRNA DegradationDaffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.Y.,
Schneller, S., Zust, R., Dong, H., et al. (2010). 20-O methylation of the viral
mRNA cap evades host restriction by IFIT family members. Nature 468,
452–456.
Ding, S.W. (2010). RNA-based antiviral immunity. Nat. Rev. Immunol. 10,
632–644.
Edge, R.E., Falls, T.J., Brown, C.W., Lichty, B.D., Atkins, H., and Bell, J.C.
(2008). A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates
tumor-specific replication. Mol. Ther. 16, 1437–1443.
Fo¨rstemann, K., Horwich, M.D., Wee, L., Tomari, Y., and Zamore, P.D. (2007).
Drosophila microRNAs are sorted into functionally distinct argonaute com-
plexes after production by dicer-1. Cell 130, 287–297.
Gehrig, S., Eberle, M.E., Botschen, F., Rimbach, K., Eberle, F., Eigenbrod, T.,
Kaiser, S., Holmes, W.M., Erdmann, V.A., Sprinzl, M., et al. (2012).
Identification of modifications in microbial, native tRNA that suppress immu-
nostimulatory activity. J. Exp. Med. 209, 225–233.
Gershon, P.D., Ahn, B.Y., Garfield, M., and Moss, B. (1991). Poly(A) poly-
merase and a dissociable polyadenylation stimulatory factor encoded by
vaccinia virus. Cell 66, 1269–1278.
Ghildiyal, M., Xu, J., Seitz, H., Weng, Z., and Zamore, P.D. (2010). Sorting of
Drosophila small silencing RNAs partitions microRNA* strands into the RNA
interference pathway. RNA 16, 43–56.
Gottwein, E., Corcoran, D.L., Mukherjee, N., Skalsky, R.L., Hafner, M.,
Nusbaum, J.D., Shamulailatpam, P., Love, C.L., Dave, S.S., Tuschl, T., et al.
(2011). Viral microRNA targetome of KSHV-infected primary effusion lym-
phoma cell lines. Cell Host Microbe 10, 515–526.
Grishok, A., Pasquinelli, A.E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D.L.,
Fire, A., Ruvkun, G., and Mello, C.C. (2001). Genes andmechanisms related to
RNA interference regulate expression of the small temporal RNAs that control
C. elegans developmental timing. Cell 106, 23–34.
Hagan, J.P., Piskounova, E., and Gregory, R.I. (2009). Lin28 recruits the
TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells.
Nat. Struct. Mol. Biol. 16, 1021–1025.
Han, B.W., Hung, J.H., Weng, Z., Zamore, P.D., and Ameres, S.L. (2011). The
30-to-50 exoribonuclease Nibbler shapes the 30 ends of microRNAs bound to
Drosophila Argonaute1. Curr. Biol. 21, 1878–1887.
Heo, I., Joo, C., Kim, Y.K., Ha, M., Yoon, M.J., Cho, J., Yeom, K.H., Han, J.,
and Kim, V.N. (2009). TUT4 in concert with Lin28 suppresses microRNA
biogenesis through pre-microRNA uridylation. Cell 138, 696–708.
Horwich, M.D., Li, C., Matranga, C., Vagin, V., Farley, G., Wang, P., and
Zamore, P.D. (2007). The Drosophila RNA methyltransferase, DmHen1,
modifies germline piRNAs and single-stranded siRNAs in RISC. Curr. Biol.
17, 1265–1272.
Hutva´gner, G., McLachlan, J., Pasquinelli, A.E., Ba´lint, E., Tuschl, T., and
Zamore, P.D. (2001). A cellular function for the RNA-interference enzyme
Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838.
Jamous, R.M., Boonrod, K., Fuellgrabe, M.W., Ali-Shtayeh, M.S., Krczal, G.,
and Wassenegger, M. (2011). The helper component-proteinase of the
Zucchini yellow mosaic virus inhibits the Hua Enhancer 1 methyltransferase
activity in vitro. J. Gen. Virol. 92, 2222–2226.
Jo¨ckel, S., Nees, G., Sommer, R., Zhao, Y., Cherkasov, D., Hori, H., Ehm, G.,
Schnare, M., Nain, M., Kaufmann, A., and Bauer, S. (2012). The 20-O-methyl-
ation status of a single guanosine controls transfer RNA-mediated Toll-like
receptor 7 activation or inhibition. J. Exp. Med. 209, 235–241.
Johnson, S.M., Lin, S.Y., and Slack, F.J. (2003). The time of appearance of the
C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal
regulatory element in its promoter. Dev. Biol. 259, 364–379.
Joklik, W.K., and Becker, Y. (1964). The Replication and Coating of Vaccinia
DNA. J. Mol. Biol. 10, 452–474.
Jopling, C.L., Norman, K.L., and Sarnow, P. (2006). Positive and negative
modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Cold Spring Harb. Symp. Quant. Biol. 71, 369–376.
Kawai, T., and Akira, S. (2006). Innate immune recognition of viral infection.
Nat. Immunol. 7, 131–137.Cell HosKawamura, Y., Saito, K., Kin, T., Ono, Y., Asai, K., Sunohara, T., Okada, T.N.,
Siomi, M.C., and Siomi, H. (2008). Drosophila endogenous small RNAs bind to
Argonaute 2 in somatic cells. Nature 453, 793–797.
Kelly, E.J., Hadac, E.M., Greiner, S., and Russell, S.J. (2008). Engineering
microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14,
1278–1283.
Ketting, R.F., Fischer, S.E., Bernstein, E., Sijen, T., Hannon, G.J., and Plasterk,
R.H. (2001). Dicer functions in RNA interference and in synthesis of small RNA
involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659.
Kim, V.N., Han, J., and Siomi, M.C. (2009). Biogenesis of small RNAs in
animals. Nat. Rev. Mol. Cell Biol. 10, 126–139.
Kincaid, R.P., Burke, J.M., and Sullivan, C.S. (2012). RNA virus microRNA that
mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. USA 109, 3077–3082.
Langlois, R.A., Shapiro, J.S., Pham, A.M., and tenOever, B.R. (2012a). In vivo
delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther. 20, 367–375.
Langlois, R.A., Varble, A., Chua, M.A., Garcı´a-Sastre, A., and tenOever, B.R.
(2012b). Hematopoietic-specific targeting of influenza A virus reveals replica-
tion requirements for induction of antiviral immune responses. Proc. Natl.
Acad. Sci. USA 109, 12117–12122.
Lecellier, C.H., Dunoyer, P., Arar, K., Lehmann-Che, J., Eyquem, S., Himber,
C., Saı¨b, A., and Voinnet, O. (2005). A cellular microRNA mediates antiviral
defense in human cells. Science 308, 557–560.
Li, J., Yang, Z., Yu, B., Liu, J., and Chen, X. (2005). Methylation protects
miRNAs and siRNAs from a 30-end uridylation activity in Arabidopsis. Curr.
Biol. 15, 1501–1507.
Liu, N., Abe, M., Sabin, L.R., Hendriks, G.J., Naqvi, A.S., Yu, Z., Cherry, S., and
Bonini, N.M. (2011). The exoribonuclease Nibbler controls 30 end processing of
microRNAs in Drosophila. Curr. Biol. 21, 1888–1893.
Lockless, S.W., Cheng, H.T., Hodel, A.E., Quiocho, F.A., and Gershon, P.D.
(1998). Recognition of capped RNA substrates by VP39, the vaccinia virus-en-
coded mRNA cap-specific 20-O-methyltransferase. Biochemistry 37, 8564–
8574.
Lo´zsa, R., Csorba, T., Lakatos, L., and Burgya´n, J. (2008). Inhibition of 30 modi-
fication of small RNAs in virus-infected plants require spatial and temporal co-
expression of small RNAs and viral silencing-suppressor proteins. Nucleic
Acids Res. 36, 4099–4107.
Marcinowski, L., Tanguy, M., Krmpotic, A., Ra¨dle, B., Lisnic, V.J., Tuddenham,
L., Chane-Woon-Ming, B., Ruzsics, Z., Erhard, F., Benkartek, C., et al. (2012).
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is
important for efficient virus replication in vivo. PLoS Pathog. 8, e1002510.
McFadden, G. (2005). Poxvirus tropism. Nat. Rev. Microbiol. 3, 201–213.
Moser, T.S., Jones, R.G., Thompson, C.B., Coyne, C.B., and Cherry, S. (2010).
A kinome RNAi screen identified AMPK as promoting poxvirus entry through
the control of actin dynamics. PLoS Pathog. 6, e1000954.
Moss, B. (2007). Poxviridae: the viruses and their replication. In Fields Virology,
Volume 2 (Philadelphia: Lippincott Williams and Wilkins), pp. 2905–2946.
Moss, B., Rosenblum, E.N., and Gershowitz, A. (1975). Characterization of
a polyriboadenylate polymerase from vaccinia virions. J. Biol. Chem. 250,
4722–4729.
Murphy, D., Dancis, B., and Brown, J.R. (2008). The evolution of core proteins
involved in microRNA biogenesis. BMC Evol. Biol. 8, 92.
Myles, K.M., Wiley, M.R., Morazzani, E.M., and Adelman, Z.N. (2008).
Alphavirus-derived small RNAsmodulate pathogenesis in disease vector mos-
quitoes. Proc. Natl. Acad. Sci. USA 105, 19938–19943.
Okamura, K., Ishizuka, A., Siomi, H., and Siomi, M.C. (2004). Distinct roles for
Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes
Dev. 18, 1655–1666.
Okamura, K., Liu, N., and Lai, E.C. (2009). Distinct mechanisms for microRNA
strand selection by Drosophila Argonautes. Mol. Cell 36, 431–444.
Pall, G.S., and Hamilton, A.J. (2008). Improved northern blot method for
enhanced detection of small RNA. Nat. Protoc. 3, 1077–1084.
Payne, L.G. (1980). Significance of extracellular enveloped virus in the in vitro
and in vivo dissemination of vaccinia. J. Gen. Virol. 50, 89–100.t & Microbe 12, 200–210, August 16, 2012 ª2012 Elsevier Inc. 209
Cell Host & Microbe
Poxviruses Mediate Host miRNA DegradationPayne, L.G., and Kristensson, K. (1985). Extracellular release of enveloped
vaccinia virus from mouse nasal epithelial cells in vivo. J. Gen. Virol. 66,
643–646.
Perez, J.T., Pham, A.M., Lorini, M.H., Chua, M.A., Steel, J., and tenOever, B.R.
(2009). MicroRNA-mediated species-specific attenuation of influenza A virus.
Nat. Biotechnol. 27, 572–576.
Pfeffer, S., Zavolan, M., Gra¨sser, F.A., Chien, M., Russo, J.J., Ju, J., John, B.,
Enright, A.J., Marks, D., Sander, C., and Tuschl, T. (2004). Identification of
virus-encoded microRNAs. Science 304, 734–736.
Pham, A.M., Langlois, R.A., and tenOever, B.R. (2012). Replication in cells of
hematopoietic origin is necessary for Dengue virus dissemination. PLoS
Pathog. 8, e1002465.
Rouha, H., Thurner, C., and Mandl, C.W. (2010). Functional microRNA gener-
ated from a cytoplasmic RNA virus. Nucleic Acids Res. 38, 8328–8337.
Saito, K., Sakaguchi, Y., Suzuki, T., Suzuki, T., Siomi, H., and Siomi, M.C.
(2007). Pimet, the Drosophila homolog of HEN1, mediates 20-O-methylation
of Piwi- interacting RNAs at their 30 ends. Genes Dev. 21, 1603–1608.
Selbach, M., Schwanha¨usser, B., Thierfelder, N., Fang, Z., Khanin, R., and
Rajewsky, N. (2008). Widespread changes in protein synthesis induced by
microRNAs. Nature 455, 58–63.
Shapiro, J.S., Varble, A., Pham, A.M., and tenOever, B.R. (2010).
Noncanonical cytoplasmic processing of viral microRNAs. RNA 16, 2068–
2074.
Shapiro, J.S., Langlois, R.A., Pham, A.M., and tenOever, B.R. (2012). Evidence
for a cytoplasmic microprocessor of pri-miRNAs. RNA 18, 1338–1346.
Shen, B., and Goodman, H.M. (2004). Uridine addition after microRNA-
directed cleavage. Science 306, 997.
Siomi, H., and Siomi, M.C. (2010). Posttranscriptional regulation of microRNA
biogenesis in animals. Mol. Cell 38, 323–332.
Siomi, M.C., Sato, K., Pezic, D., and Aravin, A.A. (2011). PIWI-interacting small
RNAs: the vanguard of genome defence. Nat. Rev. Mol. Cell Biol. 12, 246–258.210 Cell Host & Microbe 12, 200–210, August 16, 2012 ª2012 ElseviTkaczuk, K.L., Obarska, A., and Bujnicki, J.M. (2006). Molecular phylogenetics
and comparative modeling of HEN1, a methyltransferase involved in plant
microRNA biogenesis. BMC Evol. Biol. 6, 6.
Tomari, Y., Du, T., and Zamore, P.D. (2007). Sorting of Drosophila small
silencing RNAs. Cell 130, 299–308.
van Wolfswinkel, J.C., Claycomb, J.M., Batista, P.J., Mello, C.C., Berezikov,
E., and Ketting, R.F. (2009). CDE-1 affects chromosome segregation through
uridylation of CSR-1-bound siRNAs. Cell 139, 135–148.
Wang, Y., Medvid, R., Melton, C., Jaenisch, R., and Blelloch, R. (2007). DGCR8
is essential for microRNA biogenesis and silencing of embryonic stem cell self-
renewal. Nat. Genet. 39, 380–385.
Yang, J.S., and Lai, E.C. (2011). Alternative miRNA biogenesis pathways and
the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892–903.
Yang, Z., Bruno, D.P., Martens, C.A., Porcella, S.F., and Moss, B. (2010).
Simultaneous high-resolution analysis of vaccinia virus and host cell transcrip-
tomes by deep RNA sequencing. Proc. Natl. Acad. Sci. USA 107, 11513–
11518.
Yang, Z., Bruno, D.P., Martens, C.A., Porcella, S.F., and Moss, B. (2011).
Genome-wide analysis of the 50 and 30 ends of vaccinia virus early mRNAs
delineates regulatory sequences of annotated and anomalous transcripts.
J. Virol. 85, 5897–5909.
Yu, B., Yang, Z., Li, J., Minakhina, S., Yang, M., Padgett, R.W., Steward, R.,
and Chen, X. (2005). Methylation as a crucial step in plant microRNA biogen-
esis. Science 307, 932–935.
Zu¨st, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W.,
Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S., et al.
(2011). Ribose 20-O-methylation provides amolecular signature for the distinc-
tion of self and non-self mRNA dependent on the RNA sensor Mda5. Nat.
Immunol. 12, 137–143.er Inc.
